Zobrazeno 1 - 10
of 307
pro vyhledávání: '"Ferard C"'
Autor:
Crommelynck S; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France. Electronic address: samuel.crommelynck@ansm.sante.fr., Grandvuillemin A; Regional Pharmacovigilance Centre of Burgundy, University Hospital Dijon Bourgogne, 21000 Dijon, France., Ferard C; French National Agency for Medicines and Health Products Safety, ANSM, Direction for Surveillance, 93200 Saint-Denis, France., Mounier C; French National Agency for Medicines and Health Products Safety, ANSM, Direction for Surveillance, 93200 Saint-Denis, France., Gault N; French National Agency for Medicines and Health Products Safety, ANSM, General Direction for Operations, PRAC representative, 93200 Saint-Denis, France., Pierron E; French National Agency for Medicines and Health Products Safety, ANSM, Direction for Surveillance, 93200 Saint-Denis, France., Jacquot B; French National Agency for Medicines and Health Products Safety, ANSM, Direction for Surveillance, 93200 Saint-Denis, France., Vaillant T; French National Agency for Medicines and Health Products Safety, ANSM, General Direction for Operations, PRAC representative, 93200 Saint-Denis, France., Chatelet IPD; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Santé Publique France, Infectious Diseases, 94410 Saint-Maurice, France., Jacquet A; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France., Salvo F; Regional Pharmacovigilance Centre of Bordeaux, DROM, University Hospital of Bordeaux, 33000 Bordeaux, France; UMR 1219 Pharmacoepidemiology Team, Bordeaux Population Health Research Centre, Inserm, University of Bordeaux, 33000 Bordeaux, France., Alt M; Regional Pharmacovigilance Centre, University Hospital of Strasbourg, 67091 Strasbourg, France., Bagheri H; Department of Medical and ClinicalPharmacology, Centre of Pharmacovigilance, Pharmacoepidemiology and Informations on Medications, Inserm UMR 1027, University Hospital and Faculty of Medicine, 31000 Toulouse, France., Micallef J; Department of Clinical Pharmacology and Pharmacovigilance, Regional Pharmacovigilance Centre of Marseille, AP-HM, 13000 Marseille, France., Pariente A; Regional Pharmacovigilance Centre of Bordeaux, DROM, University Hospital of Bordeaux, 33000 Bordeaux, France., Gautier S; Departement of Clinical Pharmacology, University Hospital, Regional Pharmacovigilance Centre of Lille, 59000 Lille, France., Valnet-Rabier MB; Regional Pharmacovigilance Centre of Franche-Comté, University Hospital of Besançon, 25000 Besançon, France., Atzenhoffer M; University Hospital Department of Pharmacotoxicology, Regional Pharmacovigilance Centre, Civil Hospices of Lyon (HCL), 69003 Lyon, France., Lepelley M; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Regional Pharmacovigilance Centre, University Hospital of Grenoble-Alpes, 38000 Grenoble, France., Cottin J; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; University Hospital Department of Pharmacotoxicology, Regional Pharmacovigilance Centre, Civil Hospices of Lyon (HCL), 69003 Lyon, France., Lacroix I; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Department of Medical and ClinicalPharmacology, Centre of Pharmacovigilance, Pharmacoepidemiology and Informations on Medications, Inserm UMR 1027, University Hospital and Faculty of Medicine, 31000 Toulouse, France., Gras V; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Pharmacovigilance Centre, Department of Clinical Pharmacology, Amiens Picardie University Medical Centre, 80054 Amiens, France., Massy N; Regional Pharmacovigilance Centre, Clinical Pharmacology Department, Rouen University Hospital, 76031 Rouen, France., Dhanani A; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France., Vella P; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France., Shaim Y; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France., Baril L; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Santé Publique France, Infectious Diseases, 94410 Saint-Maurice, France., Jonville-Béra AP; French National Agency for Medicines and Health Products (ANSM), Direction for Medical Drugs Department, Department of Infections and Emerging Disease, 93200 Saint-Denis, France; Departement of Pharmacosurveillance, University Hospital, Regional Pharmacovigilance Centre Val-de-Loire, 37000 Tours, France., Benkebil M; French National Agency for Medicines and Health Products Safety, ANSM, Direction for Surveillance, 93200 Saint-Denis, France.
Publikováno v:
Therapie [Therapie] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Lê, A., Guillet, E., Tsarpala, E., Brun, E., Férard, C., Féral-Martin, C., Sergent, J.-A., Pallardy, M., Biola-Vidamment, A.
Publikováno v:
In Toxicology Letters September 2024 399 Supplement 2:S283-S283
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guillet É; INSERM UMR-996, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, Université Paris-Saclay, 17, Avenue Des Sciences, 91400, Orsay, France., Brun É; Institut de Chimie Physique, CNRS, Université Paris-Saclay, 91400, Orsay, France., Ferard C; Institut de Chimie Physique, CNRS, Université Paris-Saclay, 91400, Orsay, France., Hardonnière K; INSERM UMR-996, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, Université Paris-Saclay, 17, Avenue Des Sciences, 91400, Orsay, France., Nabhan M; INSERM UMR-996, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, Université Paris-Saclay, 17, Avenue Des Sciences, 91400, Orsay, France., Legrand FX; Institut Galien Paris-Saclay, CNRS, Université Paris-Saclay, 91400, Orsay, France., Pallardy M; INSERM UMR-996, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, Université Paris-Saclay, 17, Avenue Des Sciences, 91400, Orsay, France., Biola-Vidamment A; INSERM UMR-996, Inserm, Inflammation, Microbiome and Immunosurveillance, Faculté de Pharmacie, Université Paris-Saclay, 17, Avenue Des Sciences, 91400, Orsay, France. armelle.biola-vidamment@universite-paris-saclay.fr.
Publikováno v:
Particle and fibre toxicology [Part Fibre Toxicol] 2023 Apr 19; Vol. 20 (1), pp. 12. Date of Electronic Publication: 2023 Apr 19.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abou Taam M; Direction de la surveillance, ANSM, 93100 Saint-Denis, France. Electronic address: malak.abou-taam@ansm.sante.fr., Jacquot B; Direction de la surveillance, ANSM, 93100 Saint-Denis, France., Ferard C; Direction de la surveillance, ANSM, 93100 Saint-Denis, France., Thery AC; Direction de la surveillance, ANSM, 93100 Saint-Denis, France., Mounier C; Direction de la surveillance, ANSM, 93100 Saint-Denis, France., Grandvuillemin A; Centre régional de pharmacovigilance de Bourgogne, CHU de Dijon, 21079 Dijon, France., Jonville-Béra AP; Service de pharmacosurveillance, centre régional de pharmacovigilance, Centre-Val-de-Loire, CHRU de Tours, 37044 Tours, France., Perault-Pochat MC; Centre régional de pharmacovigilance du Poitou Charente, CHU de Poitiers, 86021 Poitiers, France.
Publikováno v:
Therapie [Therapie] 2021 Sep-Oct; Vol. 76 (5), pp. 441-447. Date of Electronic Publication: 2020 May 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jennyfer Miot, Karim Benzerara, Guillaume Morin, Andreas Kappler, Bernard, S., Martin Obst, Ferard, C., Skouri-Panet, F., M Guigner, J., Nicole Posth, Galvez, M., Gordon E Brown, Jr
Publikováno v:
Miot, J, Benzerara, K, Morin, G, Kappler, A, Bernard, S, Obst, M, Ferard, C, Skouri-Panet, F, Guigner, J-M, Posth, N, Galvez, M & Brown, Jr., G E 2009, ' Iron biomineralization by neutrophilic iron-oxidizing bacteria ', Geochimica et Cosmochimica Acta, vol. 73, pp. 696-711 .
University of Southern Denmark
University of Southern Denmark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::58b825b2a6acdfaae0ef94090f4230d2
https://portal.findresearcher.sdu.dk/da/publications/907ab61d-3229-4adf-87f4-5af3c6a305b5
https://portal.findresearcher.sdu.dk/da/publications/907ab61d-3229-4adf-87f4-5af3c6a305b5
